Glenn Short is the Vice President of Early Development at atai, CEO at Viridia Life Sciences, Revixia, and EmpathBio. He also fulfils the role of CSO at EntheogeniX.
Explore more info with a membership (any level)
🧑 Extended profile information
📈 In-depth psychedelic reports (Sprout & Tree)
🪄 Weekly psychedelic research & implementation newsletter (free)